1.75Open1.75Pre Close0 Volume1 Open Interest22.50Strike Price0.00Turnover0.00%IV-1.42%PremiumNov 15, 2024Expiry Date2.04Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma11.69Leverage Ratio--Theta--Rho--Eff Leverage--Vega
NetScout Systems Stock Discussion
We think it is likely we see outsized weakness in cloud names – $Datadog (DDOG.US)$ , $MongoDB (MDB.US)$ , $Snowflake (SNOW.US)$ , $Confluent (CFLT.US)$ , $Amazon (AMZN.US)$ , $Microsoft (MSFT.US)$ -- giving back some of their gains from yesterday. $Datadog (DDOG.US)$ is also a comp to $NetScout Systems (NTCT.US)$ (neg pre yesterday after the close) which could add further dnsid...
• $Bausch + Lomb Corp. (BLCO.US)$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
• $Steel Dynamics (STLD.US)$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...
• $CatchMark Timber Trust Inc (CTT.US)$ +36.4% (CatchMark Timber Trust and PotlatchDeltic (PCH) to combine in an all-stock transaction)
• $Yamana Gold (AUY.US)$ +17.0% (Yamana Gold to be acquired by Gold Fields (GFI) for $6.7 bln)
• $AMC Entertainment (AMC.US)$ +12.7% (strong "Top Gun: Maverick" box office showing)
• $KE Holdings (BEKE.US)$ +8.3% (In reaction to earnings)
• $Eledon Pharmaceuticals (ELDN.US)$ +7.7% (topline resul...
• $Grab Holdings (GRAB.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde (LIN.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream (MMP.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems (MRCY.US)$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics (NRIX.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...
No comment yet